Welcome to the Cochrane Incontinence newsletter!
Catch up on the most recent publications from the Group, as well as other news and opportunities. We would also like to thank all our contributors for their hard work and patience in a very difficult year, and look forward to a safe and healthy 2021 for all.

In this issue:

* What’s New
* Update on faecal incontinence priority setting
* News

What’s New

New updated review: Pessaries (mechanical devices) for managing pelvic organ prolapse in women
A newly updated Cochrane Review was published in November. ‘Pessaries (mechanical devices) for managing pelvic organ prolapse in women (3) has been authored by Carol Bugge, Elisabeth Adams, Deepa Gopinath, Fiona Stewart, Melanie Dembinsky, Pauline Sobiesuo and Rohna Kearney.
This new version of the review includes four studies involving a total of 478 women. A brief economic commentary has also been added to the review.
The full review is available to read on the Cochrane Library (4)

New protocol: Behavioural interventions for nocturia in adults
A new Cochrane Incontinence protocol has been published!
‘Behavioural interventions for nocturia in adults (5) has been authored by Louise Tanner, Katie Thomson, Marcus J Drake, Claire F Ervin, Wendy F Bower and Fiona Pearson, setting out the plan for the systematic review and a brief economic commentary.
The full protocol is available to read on the Cochrane Library (6).

Update on faecal incontinence priority setting
In August 2020,  we shared information about a priority setting exercise we were planning for research on faecal incontinence (7). This was to help understand what areas of treatment and management are most important to people and inform which systematic reviews we undertake.
We are thrilled to let you know we have successfully completed all three stages of this work and are in the process of writing a report based on our findings. Before this, we wanted to provide you with an update.
An incredible 68 people from around the world suggested 268 potential priority areas. We categorised their suggestions and mapped them alongside 115 identified systematic reviews and 130 clinical trials, highlighting any research gaps leading to unmet need.
Following this stage, 21 people joined us for a workshop held on 17 November 2020. Here, we discussed, refined and ranked the key priority areas previously identified. The people who attended the workshop provided a tremendous amount of valuable information on a broad range of topics.
We want to say a huge thank you to all the participants for sharing their insights – we hope you enjoy reading the final results soon!

News

New updated podcast: How effective is pelvic floor muscle training undertaken during pregnancy or after birth for preventing or treating incontinence?
An updated podcast of a recently-published Cochrane Incontinence review is available now!
‘How effective is pelvic floor muscle training undertaken during pregnancy or after birth for preventing or treating incontinence? (8)
sees authors Stephanie Woodley and Jean Hay-Smith discussing their recently-updated Cochrane review ‘Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antental and postnatal women (9). They discuss the background to the review as well as its conclusions.
Read the full review on the Cochrane Library (10)  or listen to the podcast on Cochrane.org (11). A Spanish version of the podcast (‘¿Qué efectividad tiene el entrenamiento del músculo del suelo pélvico realizado durante el embarazo o después del parto para prevenir o tratar la incontinencia?’) (12) is also available to listen to.

[3]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=69effdf3be&e=bc422de86f
[4]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=e2c10e047e&e=bc422de86f
[5]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=d650fb295a&e=bc422de86f
[6]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=bfd0c4754f&e=bc422de86f
[7]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=0bc5515600&e=bc422de86f
[8]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=da48bf76e4&e=bc422de86f
[9]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=8a7849d018&e=bc422de86f
[10]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=75453235e4&e=bc422de86f
[11]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=b690da7d5b&e=bc422de86f
[12]
https://cochrane.us16.list-manage.com/track/click?u=dd42779bd6e5d8a75d976065e&id=3d26fb7a10&e=bc422de86f